Search

everythinglearnresearchcommunity

for

Search:↓

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Isotretinoin can cause rare scalp cysts and hair loss, treatable with medication.

A woman with a rare scalp condition causing a thick scalp and hair loss didn't improve with steroid treatment.

The microbiome may be linked to hair loss and could be a target for new treatments.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Some cancer treatments can cause permanent hair loss.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Trichoscopy is useful for diagnosing hair and scalp disorders in people with darker skin.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

The hair growth product was effective and safe, increasing hair growth, thickness, and density while reducing hair fall.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Lichen simplex chronicus on the scalp can be diagnosed by specific hair and skin signs and treated with corticosteroids and therapy.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

About 61% of women who had COVID-19 experienced hair loss afterward.

The document suggests that nerve issues might contribute to hair loss and that testing sensation could predict these nerve problems.

Balding and low testosterone increase risk of urinary stones.

Scalp disease in dermatomyositis causes significant symptoms and has unique features.

Dissecting Cellulitis of the Scalp is more common in young men and often associated with head and neck acne.

6.1% of patients seeking PRP for hair loss had undiagnosed cicatricial alopecia, which PRP cannot treat.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

The evaluation system improves patient selection for hair loss surgery, leading to fewer but more successful surgeries.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

Topical 5α-reductase inhibitor helps counteract hair loss and stabilize it.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

EPDS can cause recurring scalp sores and hair loss if not treated.

Certain Prakruti types are more prone to early male pattern baldness.